speb/financial-data huggingface dataset:
Financial ratios for HANS.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -643265.9090909091
Net income: -516920.45454545453
Capital expenditures: 227272.72727272726
Operating cash flow: -677350.7575757576
Depreciation & amortization: 57518.181818181816
Net tangible assets: 683746.212121212
Owner earnings: -686675
Return on net tangible assets (%): -100.42834429308236
Buffett classification: The Gruesome
Stock price: 0.030303030303030304
Shares outstanding: 51693125
Book value: 683746.2121212122
P/B ratio: 2.2909938008631148
Market cap (USD): 1566458.3333333335
Debt to equity: 0.20416488928529877
Current ratio: 0.33186056054432156
Quick ratio: 0.33186056054432156
Free cash flow (dilution-adjusted): -919930.3030303031
Buyback yield (%): 0
Retained earnings: -6510219.696969696
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.12852809084912
Rule of 40 score: 0
Financial ratios for HANS.V — quarterly report dated 2024-09-30
Operating income: -172563.70370370368
Capital expenditures: 518518.5185185185
Buffett classification: The Gruesome
Stock price: 0.02222222222222222
Shares outstanding: 51693125
Market cap (USD): 1148736.111111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HANS.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -109581.11888111889
Net income: -152308.39160839163
Capital expenditures: 0
Operating cash flow: -50669.93006993007
Depreciation & amortization: 13274.125874125875
Net tangible assets: 268141.25874125876
Owner earnings: -139034.26573426576
Return on net tangible assets (%): -51.851127419531515
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 51693125
Book value: 268141.25874125864
P/B ratio: 2.6962682752541465
Market cap (USD): 722980.7692307694
Debt to equity: 1.9784504566531582
Current ratio: 0.040879283598928215
Quick ratio: 0.040879283598928215
Free cash flow (dilution-adjusted): -62711.88811188811
Buyback yield (%): 0
Retained earnings: -6634245.454545455
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.72087179078562
Rule of 40 score: 0
Financial ratios for HANS.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -520782.5174825175
Net income: -624811.8881118881
Capital expenditures: 489510.4895104895
Operating cash flow: -166620.97902097902
Depreciation & amortization: 53094.405594405594
Net tangible assets: 268141.25874125876
Owner earnings: -1061227.9720279719
Return on net tangible assets (%): -395.7719811601232
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 51693125
Book value: 268141.25874125864
P/B ratio: 2.6962682752541465
Market cap (USD): 722980.7692307694
Debt to equity: 1.9784504566531582
Current ratio: 0.040879283598928215
Quick ratio: 0.040879283598928215
Free cash flow (dilution-adjusted): -668173.4265734266
Buyback yield (%): 0
Retained earnings: -6634245.454545455
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.20822406469696
Rule of 40 score: 0
Financial ratios for HANS.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -92281.81818181819
Net income: -137463.63636363638
Capital expenditures: 0
Operating cash flow: -24890.209790209792
Depreciation & amortization: 6835.664335664336
Net tangible assets: 141351.04895104896
Owner earnings: -130627.97202797205
Return on net tangible assets (%): -92.4138681653573
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 51693125
Book value: 141351.0489510491
P/B ratio: 7.672183276274901
Market cap (USD): 1084471.153846154
Debt to equity: 4.244592642431674
Current ratio: 0.039363664360766805
Quick ratio: 0.039363664360766805
Free cash flow (dilution-adjusted): -24890.209790209792
Buyback yield (%): 0
Retained earnings: -6771709.090909091
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.448165267427601
Rule of 40 score: 0
Financial ratios for HANS.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -278784.6715328467
Net income: -374137.2262773722
Capital expenditures: 419708.02919708024
Operating cash flow: -46472.26277372262
Depreciation & amortization: 7135.036496350364
Net tangible assets: -67695.6204379562
Owner earnings: -786710.2189781021
Buffett classification: The Gruesome
Stock price: 0.014598540145985401
Shares outstanding: 51693125
Book value: -67695.62043795595
Market cap (USD): 754644.1605839416
Debt to equity: -16.331701583947094
Current ratio: 0.13337247754926707
Quick ratio: 0.13337247754926707
Interest coverage ratio: -7.931202757704128
Free cash flow (dilution-adjusted): -466180.2919708029
Buyback yield (%): 0
Retained earnings: -7442417.518248174
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.86073923207408
Rule of 40 score: 0
Financial ratios for HANS.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -112329.4964028777
Net income: -198315.82733812951
Capital expenditures: 0
Operating cash flow: -128804.3165467626
Depreciation & amortization: 7032.374100719425
Net tangible assets: -265037.4100719425
Owner earnings: -191283.45323741008
Buffett classification: The Gruesome
Stock price: 0.02158273381294964
Shares outstanding: 51693125
Book value: -265037.4100719425
Market cap (USD): 1115678.9568345323
Debt to equity: -4.435839110536858
Current ratio: 0.12257271329125582
Quick ratio: 0.12257271329125582
Free cash flow (dilution-adjusted): -128804.3165467626
Buyback yield (%): 0
Retained earnings: -7533648.20143885
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.335416386863335
Rule of 40 score: 0
Financial ratios for HCAI — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2973514.2259414224
Buffett classification: The Gruesome
Stock price: 24.27
Shares outstanding: 629942
Book value: 5010908.786610879
P/B ratio: 3.0510817480556227
Market cap (USD): 15288692.34
Debt to equity: 0.3077898718934444
Current ratio: 2.7166209697820407
Quick ratio: 2.5082123624542803
Buyback yield (%): 0
Retained earnings: 2467215.620641562
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.51
Shares outstanding: 128350881
Market cap (USD): 2504125688.3100004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESM — annual report dated 2022-12-31
Total revenue: 1273200000
Gross profit: 1091900000
Operating income: 791200000
Net income: 620600000
Capital expenditures: 238200000
Operating cash flow: 861100000
Depreciation & amortization: 181300000
Net tangible assets: 245100000
Owner earnings: 563700000
Return on net tangible assets (%): 229.98776009791922
Capex to operating income (%): 30.1061678463094
Buffett classification: The Good
Stock price: 22.75
P/E ratio: 4.7050959438446665
Shares outstanding: 128350881
Book value: 529000000
P/B ratio: 5.519815770793951
Market cap (USD): 2919982542.75
Debt to equity: 5.454820415879017
Current ratio: 0.8294670846394985
Quick ratio: 0.8294670846394985
Effective tax rate (%): 4.1100123609394315
Interest coverage ratio: 5.29939718687207
COGS to revenue (%): 14.2397109644989
SG&A to revenue (%): 1.814326107445806
Free cash flow (dilution-adjusted): 621300000
Buyback yield (%): 13.698712034876943
Receivables turnover: 10.351219512195122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.075801324117013
FCF margin (%): 48.79830348727616
Rule of 40 score: 48.79830348727616
Financial ratios for HESM — annual report dated 2023-12-31
Total revenue: 1346100000
Gross profit: 1153600000
Operating income: 816900000
Net income: 607700000
Capital expenditures: 223500000
Operating cash flow: 866400000
Depreciation & amortization: 192500000
Net tangible assets: 340200000
Owner earnings: 576700000
Return on net tangible assets (%): 169.51793062904176
Capex to operating income (%): 27.35952993022402
Buffett classification: The Good
Stock price: 26.02
P/E ratio: 5.495622714530195
Shares outstanding: 128350881
Book value: 363200000
P/B ratio: 9.195181507764318
Market cap (USD): 3339689923.62
Debt to equity: 8.841960352422907
Current ratio: 0.6508087535680305
Quick ratio: 0.6508087535680305
Effective tax rate (%): 5.870508054522924
Interest coverage ratio: 4.563687150837989
COGS to revenue (%): 14.300572022880914
SG&A to revenue (%): 1.9463635688284675
Free cash flow (dilution-adjusted): 641200000
Buyback yield (%): 11.977159830647595
Receivables turnover: 10.820739549839228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.822898332076104
FCF margin (%): 47.63390535621425
Revenue growth (%): 5.725730442978323
Rule of 40 score: 53.359635799192574
Financial ratios for HESM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.73
Shares outstanding: 128350881
Market cap (USD): 3944222573.13
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESM — annual report dated 2024-12-31
Total revenue: 1491900000
Gross profit: 1288800000
Operating income: 919000000
Net income: 659000000
Capital expenditures: 306100000
Operating cash flow: 940300000
Depreciation & amortization: 203100000
Net tangible assets: 530700000
Owner earnings: 556000000
Return on net tangible assets (%): 104.76728848690409
Capex to operating income (%): 33.30794341675735
Buffett classification: The Good
Stock price: 32.9
P/E ratio: 6.407805743399089
Shares outstanding: 128350881
Book value: 465300000
P/B ratio: 9.075314818181818
Market cap (USD): 4222743984.8999996
Debt to equity: 7.461637653127015
Current ratio: 0.6812585499316005
Quick ratio: 0.6812585499316005
Effective tax rate (%): 9.824849480021895
Interest coverage ratio: 4.545004945598418
COGS to revenue (%): 13.613512970038204
SG&A to revenue (%): 1.7494470138749247
Free cash flow (dilution-adjusted): 632400000
Buyback yield (%): 7.104385230853734
Receivables turnover: 10.740820734341252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.374112979118447
FCF margin (%): 42.38890006032576
Revenue growth (%): 10.831290394472921
Rule of 40 score: 53.22019045479868
Financial ratios for HESM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.9
Shares outstanding: 128350881
Market cap (USD): 4222743984.8999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HESM — quarterly report dated 2025-03-31
Total revenue: 381000000
Gross profit: 329500000
Operating income: 237400000
Net income: 161400000
Capital expenditures: 45500000
Operating cash flow: 202400000
Depreciation & amortization: 51500000
Net tangible assets: 601300000
Owner earnings: 167400000
Return on net tangible assets (%): 27.839680691834356
Capex to operating income (%): 19.165964616680707
Buffett classification: The Great
Stock price: 38.21
P/E ratio: 7.596479496607807
Shares outstanding: 128350881
Book value: 512900000
P/B ratio: 9.561877876798597
Market cap (USD): 4904287163.01
Debt to equity: 6.963930590758433
Current ratio: 0.8065556152606126
Quick ratio: 0.8065556152606126
Effective tax rate (%): 12.472885032537961
Interest coverage ratio: 4.209219858156028
COGS to revenue (%): 13.517060367454068
SG&A to revenue (%): 1.968503937007874
Free cash flow (dilution-adjusted): 156600000
Buyback yield (%): 2.039032313487637
Receivables turnover: 2.7078891257995736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.822194972409565
FCF margin (%): 41.10236220472441
Rule of 40 score: 41.10236220472441
Financial ratios for HESM — quarterly report dated 2025-06-30
Total revenue: 413500000
Gross profit: 361700000
Operating income: 260200000
Net income: 179700000
Capital expenditures: 63400000
Operating cash flow: 276900000
Depreciation & amortization: 51800000
Net tangible assets: 635000000
Owner earnings: 168100000
Return on net tangible assets (%): 26.472440944881892
Capex to operating income (%): 24.36587240584166
Buffett classification: The Great
Stock price: 35.46
P/E ratio: 13.343073117150396
Shares outstanding: 128350881
Book value: 507600000
P/B ratio: 8.966355871276596
Market cap (USD): 4551322240.26
Debt to equity: 7.317572892040977
Current ratio: 0.7067915690866511
Quick ratio: 0.7067915690866511
Effective tax rate (%): 13.936781609195403
Interest coverage ratio: 4.696750902527076
COGS to revenue (%): 12.52720677146312
SG&A to revenue (%): 1.9588875453446193
Free cash flow (dilution-adjusted): 213200000
Buyback yield (%): 4.394327394154687
Receivables turnover: 2.8715277777777777
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.181109844165716
FCF margin (%): 51.55985489721886
Revenue growth (%): 8.530183727034121
Rule of 40 score: 60.09003862425298
Financial ratios for HESM — quarterly report dated 2025-09-30
Total revenue: 419600000
Gross profit: 363000000
Operating income: 258900000
Net income: 175500000
Capital expenditures: 80000000
Operating cash flow: 258900000
Depreciation & amortization: 56600000
Net tangible assets: 572500000
Owner earnings: 152100000
Return on net tangible assets (%): 26.56768558951965
Capex to operating income (%): 30.899961375048278
Buffett classification: The Good
Stock price: 32.39
P/E ratio: 8.047396507142857
Shares outstanding: 128350881
Book value: 426500000
P/B ratio: 9.747444397631886
Market cap (USD): 4157285035.59
Debt to equity: 8.897772567409143
Current ratio: 0.7498885421310745
Quick ratio: 0.7498885421310745
Effective tax rate (%): 15.217391304347828
Interest coverage ratio: 4.53415061295972
COGS to revenue (%): 13.489037178265015
SG&A to revenue (%): 1.7397521448999045
Free cash flow (dilution-adjusted): 178100000
Buyback yield (%): 2.4054160141513616
Receivables turnover: 2.7880398671096347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.144681255043433
FCF margin (%): 42.445185891325075
Revenue growth (%): 1.475211608222491
Rule of 40 score: 43.92039749954757
Financial ratios for HESM — annual report dated 2025-12-31
Total revenue: 1617200000
Gross profit: 1403100000
Operating income: 1008100000
Net income: 684600000
Capital expenditures: 255600000
Operating cash flow: 983800000
Depreciation & amortization: 214100000
Net tangible assets: 568300000
Owner earnings: 643100000
Return on net tangible assets (%): 113.16206229104347
Capex to operating income (%): 25.3546275171114
Buffett classification: The Good
Stock price: 33.08
P/E ratio: 6.20193856774759
Shares outstanding: 128350881
Book value: 437900000
P/B ratio: 9.695928621785797
Market cap (USD): 4245847143.48
Debt to equity: 8.61383877597625
Current ratio: 0.8466453674121406
Quick ratio: 0.8466453674121406
Effective tax rate (%): 14.253507014028056
Interest coverage ratio: 4.468528368794326
COGS to revenue (%): 13.238931486519911
SG&A to revenue (%): 1.7623052188968586
Free cash flow (dilution-adjusted): 726600000
Buyback yield (%): 9.420970338375165
Receivables turnover: 10.766977363515313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.999523866206403
FCF margin (%): 44.92950779124413
Revenue growth (%): 8.398686239024062
Rule of 40 score: 53.32819403026819
Financial ratios for HESM — quarterly report dated 2025-12-31
Total revenue: 403100000
Gross profit: 348900000
Operating income: 251600000
Net income: 168000000
Capital expenditures: 66700000
Operating cash flow: 245600000
Depreciation & amortization: 54200000
Net tangible assets: 568300000
Owner earnings: 155500000
Return on net tangible assets (%): 27.362308639802922
Capex to operating income (%): 26.510333863275036
Buffett classification: The Good
Stock price: 33.08
P/E ratio: 6.20193856774759
Shares outstanding: 128350881
Book value: 437900000
P/B ratio: 9.695928621785797
Market cap (USD): 4245847143.48
Debt to equity: 8.61383877597625
Current ratio: 0.8466453674121406
Quick ratio: 0.8466453674121406
Effective tax rate (%): 15.237134207870836
Interest coverage ratio: 4.4373897707231045
COGS to revenue (%): 13.445795088067477
SG&A to revenue (%): 1.38923344083354
Free cash flow (dilution-adjusted): 178700000
Buyback yield (%): 0
Receivables turnover: 2.6837549933422102
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.989763123437686
FCF margin (%): 44.33143140659886
Revenue growth (%): -3.932316491897045
Rule of 40 score: 40.39911491470181
Financial ratios for HGH.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.075187969924812
Shares outstanding: 1030260000
Market cap (USD): 1107723157.8947368
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HGH.AX — annual report dated 2022-06-30
Total revenue: 164191925.4658385
Net income: 59083850.93167701
Capital expenditures: 6092546.583850931
Depreciation & amortization: 8567701.863354037
Net tangible assets: 366355900.621118
Owner earnings: 61559006.21118012
Return on net tangible assets (%): 16.803061205459848
Buffett classification: The Gruesome
Stock price: 0.896551724137931
P/E ratio: 15.633398377815036
Shares outstanding: 1030260000
Book value: 502302484.4720497
P/B ratio: 1.8388947056098874
Market cap (USD): 923681379.3103448
Debt to equity: 3.208149552310045
Effective tax rate (%): 30.58646682379726
COGS to revenue (%): 0
SG&A to revenue (%): 1.0134329995574034
Free cash flow (dilution-adjusted): -169020496.89440992
Buyback yield (%): 0
Retained earnings: 123966459.62732919
Receivables turnover: 0.04300529665876782
Capitalized R&D asset: 0
FCF margin (%): -102.94080930890604
Rule of 40 score: -102.94080930890604
Financial ratios for HGH.AX — annual report dated 2023-06-30
Total revenue: 170989090.9090909
Net income: 58101818.18181819
Capital expenditures: 14950909.090909092
Depreciation & amortization: 8233333.333333334
Net tangible assets: 481982424.24242425
Owner earnings: 51384242.42424243
Return on net tangible assets (%): 10.661019954204292
Buffett classification: The Gruesome
Stock price: 0.847682119205298
P/E ratio: 15.03107832872849
Shares outstanding: 1030260000
Book value: 624850909.0909095
P/B ratio: 1.3976661751249677
Market cap (USD): 873332980.1324503
Debt to equity: 2.4351622302144307
Effective tax rate (%): 28.452978886956775
COGS to revenue (%): 0
SG&A to revenue (%): 1.1423730735967563
Free cash flow (dilution-adjusted): 10921212.121212121
Buyback yield (%): 0
Retained earnings: 135789090.9090909
Receivables turnover: 0.04186032847654292
Capitalized R&D asset: 0
FCF margin (%): 6.3870812243914195
Revenue growth (%): 4.139768398456733
Rule of 40 score: 10.526849622848152
Financial ratios for HGH.AX — annual report dated 2024-06-30
Total revenue: 175887804.87804878
Net income: 45456707.317073174
Capital expenditures: 17128658.53658537
Depreciation & amortization: 8828658.536585366
Net tangible assets: 584123780.4878049
Owner earnings: 37156707.317073174
Return on net tangible assets (%): 6.361101629186096
Buffett classification: The Gruesome
Stock price: 0.54
P/E ratio: 12.238906705656683
Shares outstanding: 1030260000
Book value: 754798170.7317076
P/B ratio: 0.737071738608851
Market cap (USD): 556340400
Debt to equity: 1.6629699911703093
Effective tax rate (%): 28.691950834568843
COGS to revenue (%): 0
SG&A to revenue (%): 1.2462905954460992
Free cash flow (dilution-adjusted): 548940243.902439
Buyback yield (%): 0
Retained earnings: 138665243.90243903
Receivables turnover: 0.040221425882287325
Capitalized R&D asset: 0
FCF margin (%): 312.09681892559
Revenue growth (%): 2.8649277815988574
Rule of 40 score: 314.96174670718887
Financial ratios for HST — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.7
Shares outstanding: 684879281
Market cap (USD): 9382846149.699999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HST — annual report dated 2022-12-31
Total revenue: 4907000000
Gross profit: 2710000000
Operating income: 758000000
Net income: 643000000
Capital expenditures: 504000000
Operating cash flow: 1416000000
Depreciation & amortization: 664000000
Net tangible assets: 6710000000
Owner earnings: 803000000
Return on net tangible assets (%): 11.967213114754099
Capex to operating income (%): 66.49076517150397
Buffett classification: The Good
Stock price: 13.07
P/E ratio: 13.921263145676518
Shares outstanding: 684879281
Book value: 6879000000
P/B ratio: 1.301260677812182
Market cap (USD): 8951372202.67
Debt to equity: 0.6953045500799535
Current ratio: 0.958827634333566
Quick ratio: 0.958827634333566
Effective tax rate (%): 3.8863976083707024
Interest coverage ratio: 4.858974358974359
COGS to revenue (%): 44.772773588750766
SG&A to revenue (%): 2.1805583859792135
Free cash flow (dilution-adjusted): 886000000
Buyback yield (%): 0.3016297321649354
Retained earnings: -939000000
Receivables turnover: 9.678500986193294
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.995201181247693
FCF margin (%): 18.055838597921337
Rule of 40 score: 18.055838597921337
Financial ratios for HST — annual report dated 2023-12-31
Total revenue: 5311000000
Gross profit: 2850000000
Operating income: 741000000
Net income: 752000000
Capital expenditures: 646000000
Operating cash flow: 1441000000
Depreciation & amortization: 697000000
Net tangible assets: 6633000000
Owner earnings: 803000000
Return on net tangible assets (%): 12.106135986733001
Capex to operating income (%): 87.17948717948718
Buffett classification: The Gruesome
Stock price: 16.67
P/E ratio: 15.182097891316493
Shares outstanding: 684879281
Book value: 6826000000
P/B ratio: 1.6725663073937886
Market cap (USD): 11416937614.27
Debt to equity: 0.6990917081746264
Current ratio: 1.0684462696783026
Quick ratio: 1.0684462696783026
Effective tax rate (%): 4.568527918781726
Interest coverage ratio: 3.8795811518324608
COGS to revenue (%): 46.33778949350405
SG&A to revenue (%): 2.165317266051591
Free cash flow (dilution-adjusted): 765000000
Buyback yield (%): 1.5941227512053555
Retained earnings: -839000000
Receivables turnover: 26.555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.872565386755704
FCF margin (%): 14.404067030691017
Revenue growth (%): 8.23313633584675
Rule of 40 score: 22.63720336653777
Financial ratios for HST — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.56
Shares outstanding: 684879281
Market cap (USD): 10656721612.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HST — annual report dated 2024-12-31
Total revenue: 5684000000
Gross profit: 3033000000
Operating income: 771000000
Net income: 707000000
Capital expenditures: 548000000
Operating cash flow: 1498000000
Depreciation & amortization: 762000000
Net tangible assets: 6609000000
Owner earnings: 921000000
Return on net tangible assets (%): 13.935542442124376
Capex to operating income (%): 71.07652399481194
Buffett classification: The Good
Stock price: 15.76
P/E ratio: 15.266898823988685
Shares outstanding: 684879281
Book value: 6777000000
P/B ratio: 1.5926955096001179
Market cap (USD): 10793697468.56
Debt to equity: 0.8326693227091634
Current ratio: 0.6521116678596993
Quick ratio: 0.6521116678596993
Effective tax rate (%): 1.9417475728155338
Interest coverage ratio: 3.5860465116279068
COGS to revenue (%): 46.63969035890218
SG&A to revenue (%): 2.0584095707248418
Free cash flow (dilution-adjusted): 926000000
Buyback yield (%): 0.9913192426568447
Retained earnings: -777000000
Receivables turnover: 49.426086956521736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.6174577289503045
FCF margin (%): 16.291344123856437
Revenue growth (%): 7.023159480323857
Rule of 40 score: 23.314503604180295
Financial ratios for HST — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.76
Shares outstanding: 684879281
Market cap (USD): 10793697468.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HST — quarterly report dated 2025-03-31
Total revenue: 1594000000
Gross profit: 866000000
Operating income: 275000000
Net income: 251000000
Capital expenditures: 146000000
Operating cash flow: 305000000
Depreciation & amortization: 196000000
Net tangible assets: 6650000000
Owner earnings: 301000000
Return on net tangible assets (%): 4.526315789473685
Capex to operating income (%): 53.090909090909086
Buffett classification: The Good
Stock price: 12.96
P/E ratio: 8.84067279059761
Shares outstanding: 684879281
Book value: 6786000000
P/B ratio: 1.3079922607957561
Market cap (USD): 8876035481.76
Debt to equity: 0.8317123489537283
Current ratio: 0.6273291925465838
Quick ratio: 0.6273291925465838
Effective tax rate (%): -0.4
Interest coverage ratio: 4.824561403508772
COGS to revenue (%): 45.67126725219573
SG&A to revenue (%): 1.944792973651192
Free cash flow (dilution-adjusted): 153000000
Buyback yield (%): 1.1266291150536425
Retained earnings: -668000000
Receivables turnover: 13.741379310344827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.358692855304915
FCF margin (%): 9.598494353826851
Rule of 40 score: 9.598494353826851
Financial ratios for HST — quarterly report dated 2025-06-30
Total revenue: 1586000000
Gross profit: 863000000
Operating income: 268000000
Net income: 225000000
Capital expenditures: 152000000
Operating cash flow: 444000000
Depreciation & amortization: 195000000
Net tangible assets: 6638000000
Owner earnings: 268000000
Return on net tangible assets (%): 4.037360650798433
Capex to operating income (%): 56.71641791044776
Buffett classification: The Good
Stock price: 14.19
P/E ratio: 20.41688444829832
Shares outstanding: 684879281
Book value: 6777000000
P/B ratio: 1.4340323147985834
Market cap (USD): 9718436997.39
Debt to equity: 0.8326693227091634
Current ratio: 0.6558891454965358
Quick ratio: 0.6558891454965358
Effective tax rate (%): 10.714285714285714
Interest coverage ratio: 4.620689655172414
COGS to revenue (%): 45.58638083228247
SG&A to revenue (%): 1.5762925598991173
Free cash flow (dilution-adjusted): 287000000
Buyback yield (%): 1.0804206481782923
Retained earnings: -585000000
Receivables turnover: 19.10843373493976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2982591544464452
FCF margin (%): 18.095838587641865
Revenue growth (%): -0.5018820577164366
Rule of 40 score: 17.59395652992543
Financial ratios for HST — quarterly report dated 2025-09-30
Total revenue: 1331000000
Gross profit: 676000000
Operating income: 96000000
Net income: 163000000
Capital expenditures: 156000000
Operating cash flow: 218000000
Depreciation & amortization: 196000000
Net tangible assets: 6661000000
Owner earnings: 203000000
Return on net tangible assets (%): 3.0475904518841013
Capex to operating income (%): 162.5
Buffett classification: The Gruesome
Stock price: 15.91
P/E ratio: 17.052315118482003
Shares outstanding: 684879281
Book value: 6813000000
P/B ratio: 1.5993584853530016
Market cap (USD): 10896429360.710001
Debt to equity: 0.8282694848084544
Current ratio: 0.7536121673003803
Quick ratio: 0.7536121673003803
Effective tax rate (%): 5.232558139534884
Interest coverage ratio: 1.6
COGS to revenue (%): 49.21111945905334
SG&A to revenue (%): 2.0285499624342602
Free cash flow (dilution-adjusted): 57000000
Buyback yield (%): 0
Retained earnings: -563000000
Receivables turnover: 6.190697674418605
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8187633262260128
FCF margin (%): 4.2824943651389935
Revenue growth (%): -16.078184110970998
Rule of 40 score: -11.795689745832004
Financial ratios for HST — annual report dated 2025-12-31
Total revenue: 6114000000
Gross profit: 3216000000
Operating income: 831000000
Net income: 776000000
Capital expenditures: 644000000
Operating cash flow: 1510000000
Depreciation & amortization: 795000000
Net tangible assets: 6558000000
Owner earnings: 927000000
Return on net tangible assets (%): 14.135407136322051
Capex to operating income (%): 77.49699157641395
Buffett classification: The Gruesome
Stock price: 16.9
P/E ratio: 14.915541042396905
Shares outstanding: 684879281
Book value: 6732000000
P/B ratio: 1.7193196448158048
Market cap (USD): 11574459848.9
Debt to equity: 0.8377896613190731
Current ratio: 0.7862648913805186
Quick ratio: 0.7862648913805186
Effective tax rate (%): 5.134474327628362
Interest coverage ratio: 3.5361702127659576
COGS to revenue (%): 47.399411187438666
SG&A to revenue (%): 2.0281321557082106
Free cash flow (dilution-adjusted): 840000000
Buyback yield (%): 1.7711409661979391
Retained earnings: -670000000
Receivables turnover: 39.96078431372549
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.1502323180175535
FCF margin (%): 13.738959764474975
Revenue growth (%): 7.565095003518649
Rule of 40 score: 21.304054767993623
Financial ratios for HST — quarterly report dated 2025-12-31
Total revenue: 1603000000
Gross profit: 811000000
Operating income: 192000000
Net income: 137000000
Capital expenditures: 190000000
Operating cash flow: 543000000
Depreciation & amortization: 208000000
Net tangible assets: 6558000000
Owner earnings: 155000000
Return on net tangible assets (%): 2.363525465080817
Capex to operating income (%): 98.95833333333334
Buffett classification: The Gruesome
Stock price: 16.9
P/E ratio: 14.915541042396905
Shares outstanding: 684879281
Book value: 6732000000
P/B ratio: 1.7193196448158048
Market cap (USD): 11574459848.9
Debt to equity: 0.8377896613190731
Current ratio: 0.7862648913805186
Quick ratio: 0.7862648913805186
Effective tax rate (%): 4.861111111111112
Interest coverage ratio: 3.2
COGS to revenue (%): 49.40736119775421
SG&A to revenue (%): 2.5577043044291954
Free cash flow (dilution-adjusted): 343000000
Buyback yield (%): 0
Retained earnings: -670000000
Receivables turnover: 10.477124183006536
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6520392359318534
FCF margin (%): 21.397379912663755
Revenue growth (%): 20.435762584522916
Rule of 40 score: 41.83314249718667
Financial ratios for HYLN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.2
Shares outstanding: 178327240
Market cap (USD): 1105628888
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYLN — annual report dated 2022-12-31
Total revenue: 2106000
Gross profit: -6672000
Operating income: -159030000
Net income: -153357000
Capital expenditures: 2733000
Operating cash flow: -116877000
Depreciation & amortization: 1227000
Net tangible assets: 423374000
Owner earnings: -154863000
Return on net tangible assets (%): -36.57829720294586
Buffett classification: The Gruesome
Stock price: 2.34
Shares outstanding: 178327240
Book value: 423574000
P/B ratio: 0.9851542861459861
Market cap (USD): 417285741.59999996
Debt to equity: 0.017279153111380775
Current ratio: 22.082345729464652
Quick ratio: 22.07730554420379
COGS to revenue (%): 416.8091168091168
R&D to revenue (%): 5240.740740740741
SG&A to revenue (%): 1993.7321937321935
Free cash flow (dilution-adjusted): -141169000
Buyback yield (%): 0
Retained earnings: 25746000
Inventory turnover: 118.62162162162163
Receivables turnover: 1.8538732394366197
Capitalized R&D asset: 110370000
ROCI (R&D-adjusted, %): -15.753155700909424
FCF margin (%): -6703.18138651472
Rule of 40 score: -6703.18138651472
Financial ratios for HYLN — annual report dated 2023-12-31
Total revenue: 672000
Gross profit: -1044000
Operating income: -125895000
Net income: -123510000
Capital expenditures: 7399000
Operating cash flow: -116962000
Depreciation & amortization: 3511000
Net tangible assets: 306266000
Owner earnings: -127398000
Return on net tangible assets (%): -41.59717369868024
Buffett classification: The Gruesome
Stock price: 0.81
Shares outstanding: 178327240
Book value: 306266000
P/B ratio: 0.47163271273990587
Market cap (USD): 144445064.4
Debt to equity: 0.024942370357793554
Current ratio: 12.015672530088613
Quick ratio: 12.015672530088613
COGS to revenue (%): 255.35714285714283
R&D to revenue (%): 12238.095238095239
SG&A to revenue (%): 6340.922619047619
Free cash flow (dilution-adjusted): -130580000
Buyback yield (%): 0.022846055790882388
Retained earnings: -97764000
Receivables turnover: 16.8
Capitalized R&D asset: 156187900
ROCI (R&D-adjusted, %): -22.97552158144014
Rosenberg metric: 0.05099211742321283
FCF margin (%): -19431.547619047622
Revenue growth (%): -68.09116809116809
Rule of 40 score: -19499.63878713879
Financial ratios for HYLN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 178327240
Market cap (USD): 442251555.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYLN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.61
Shares outstanding: 178327240
Market cap (USD): 465434096.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYLN — annual report dated 2024-12-31
Total revenue: 1509000
Gross profit: 94000
Operating income: -61292000
Net income: -52048000
Capital expenditures: 11140000
Operating cash flow: -56738000
Depreciation & amortization: 3147000
Net tangible assets: 244389000
Owner earnings: -60041000
Return on net tangible assets (%): -24.56779969638568
Buffett classification: The Gruesome
Stock price: 2.61
Shares outstanding: 178327240
Book value: 244389000
P/B ratio: 1.904480546996796
Market cap (USD): 465434096.4
Debt to equity: 0.027791758221523882
Current ratio: 9.168847526415226
Quick ratio: 9.168847526415226
COGS to revenue (%): 93.77070907886016
R&D to revenue (%): 2452.22001325381
SG&A to revenue (%): 1615.772034459907
Free cash flow (dilution-adjusted): -77878000
Buyback yield (%): 3.0040772921766545
Retained earnings: -149812000
Receivables turnover: 0.7847113884555382
Capitalized R&D asset: 128526900
ROCI (R&D-adjusted, %): -26.72431410041139
Rosenberg metric: 0.013837548638132295
FCF margin (%): -5160.901259111995
Revenue growth (%): 124.55357142857142
Rule of 40 score: -5036.347687683424
Financial ratios for HYLN — quarterly report dated 2025-03-31
Total revenue: 489000
Gross profit: 12000
Operating income: -18299000
Net income: -17254000
Capital expenditures: 7115000
Operating cash flow: -14004000
Depreciation & amortization: 1142000
Net tangible assets: 227987000
Owner earnings: -23227000
Return on net tangible assets (%): -10.18786158859935
Buffett classification: The Gruesome
Stock price: 1.4
Shares outstanding: 178327240
Book value: 227987000
P/B ratio: 1.0950542618658081
Market cap (USD): 249658135.99999997
Debt to equity: 0.02722523652664406
Current ratio: 13.852457241827235
Quick ratio: 13.852457241827235
COGS to revenue (%): 97.54601226993866
R&D to revenue (%): 2501.0224948875257
SG&A to revenue (%): 1243.558282208589
Free cash flow (dilution-adjusted): -22633000
Buyback yield (%): 0
Retained earnings: -167066000
Receivables turnover: 0.24609964771011575
Capitalized R&D asset: 12230000
ROCI (R&D-adjusted, %): -4.158605500174886
FCF margin (%): -4628.4253578732105
Rule of 40 score: -4628.4253578732105
Financial ratios for HYLN — quarterly report dated 2025-06-30
Total revenue: 1515000
Gross profit: 131000
Operating income: -15969000
Net income: -13414000
Capital expenditures: 3660000
Operating cash flow: -9995000
Depreciation & amortization: 1286000
Net tangible assets: 215870000
Owner earnings: -15788000
Return on net tangible assets (%): -7.313660999675731
Buffett classification: The Gruesome
Stock price: 1.32
Shares outstanding: 178327240
Book value: 215870000
P/B ratio: 1.0904338574141845
Market cap (USD): 235391956.8
Debt to equity: 0.025987863065734005
Current ratio: 11.163953601715567
Quick ratio: 11.163953601715567
COGS to revenue (%): 91.35313531353135
R&D to revenue (%): 669.1089108910891
SG&A to revenue (%): 393.5973597359736
Free cash flow (dilution-adjusted): -15622000
Buyback yield (%): 0
Retained earnings: -180480000
Receivables turnover: 1.270973154362416
Capitalized R&D asset: 18331100
ROCI (R&D-adjusted, %): -5.599944819548827
Rosenberg metric: 0.00973017170891251
FCF margin (%): -1031.1551155115512
Revenue growth (%): 209.8159509202454
Rule of 40 score: -821.3391645913058
Financial ratios for HYLN — quarterly report dated 2025-09-30
Total revenue: 759000
Gross profit: -47000
Operating income: -15367000
Net income: -13337000
Capital expenditures: 10036000
Operating cash flow: -10692000
Depreciation & amortization: 1638000
Net tangible assets: 203856000
Owner earnings: -21735000
Return on net tangible assets (%): -10.661937838474216
Buffett classification: The Gruesome
Stock price: 1.97
Shares outstanding: 178327240
Book value: 203856000
P/B ratio: 1.7232981261282474
Market cap (USD): 351304662.8
Debt to equity: 0.02451240091044659
Current ratio: 11.015025543423821
Quick ratio: 11.015025543423821
COGS to revenue (%): 106.1923583662714
R&D to revenue (%): 1335.441370223979
SG&A to revenue (%): 683.0039525691699
Free cash flow (dilution-adjusted): -22498000
Buyback yield (%): 0
Retained earnings: -193817000
Receivables turnover: 1.0454545454545454
Capitalized R&D asset: 20963690
ROCI (R&D-adjusted, %): -7.070583349679913
Rosenberg metric: -0.017559435730492255
FCF margin (%): -2964.163372859025
Revenue growth (%): -49.9009900990099
Rule of 40 score: -3014.064362958035
Financial ratios for HYLN — annual report dated 2025-12-31
Total revenue: 3475000
Gross profit: 170000
Operating income: -65054000
Net income: -57188000
Capital expenditures: 21506000
Operating cash flow: -46549000
Depreciation & amortization: 5956000
Net tangible assets: 192009000
Owner earnings: -72738000
Return on net tangible assets (%): -37.88259925316001
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 178327240
Book value: 192009000
P/B ratio: 1.7088892791483732
Market cap (USD): 328122121.6
Debt to equity: 0.02276976600055206
Current ratio: 10.000202778059414
Quick ratio: 10.000202778059414
COGS to revenue (%): 95.10791366906474
R&D to revenue (%): 1222.0719424460433
SG&A to revenue (%): 654.8776978417267
Free cash flow (dilution-adjusted): -75767000
Buyback yield (%): 0
Retained earnings: -207000000
Receivables turnover: 7.106339468302658
Capitalized R&D asset: 94398880
ROCI (R&D-adjusted, %): -26.55051234047153
Rosenberg metric: 0.002053832018160199
FCF margin (%): -2180.345323741007
Revenue growth (%): 130.28495692511598
Rule of 40 score: -2050.060366815891
Financial ratios for HYLN — quarterly report dated 2025-12-31
Total revenue: 712000
Gross profit: 74000
Operating income: -15419000
Net income: -13183000
Capital expenditures: 695000
Operating cash flow: -11858000
Depreciation & amortization: 1890000
Net tangible assets: 192009000
Owner earnings: -11988000
Return on net tangible assets (%): -6.243457337937284
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 178327240
Book value: 192009000
P/B ratio: 1.7088892791483732
Market cap (USD): 328122121.6
Debt to equity: 0.02276976600055206
Current ratio: 10.000202778059414
Quick ratio: 10.000202778059414
COGS to revenue (%): 89.60674157303372
R&D to revenue (%): 1399.438202247191
SG&A to revenue (%): 776.5449438202247
Free cash flow (dilution-adjusted): -15014000
Buyback yield (%): 0
Retained earnings: -207000000
Receivables turnover: 1.456032719836401
Capitalized R&D asset: 20100330
ROCI (R&D-adjusted, %): -7.26579357091864
Rosenberg metric: 0.011937647987371744
FCF margin (%): -2108.7078651685392
Revenue growth (%): -6.192358366271409
Rule of 40 score: -2114.9002235348107
Financial ratios for IDN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.62
Shares outstanding: 20251221
Market cap (USD): 93560641.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDN — annual report dated 2022-12-31
Total revenue: 15966000
Gross profit: 14691000
Operating income: -4030000
Net income: -4159000
Capital expenditures: 192000
Operating cash flow: -3480000
Depreciation & amortization: 285000
Net tangible assets: 9292000
Owner earnings: -4066000
Return on net tangible assets (%): -43.75807145931985
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 20251221
Book value: 17667000
P/B ratio: 2.292547800984887
Market cap (USD): 40502442
Debt to equity: 0
Current ratio: 2.7839080459770114
Quick ratio: 2.7839080459770114
Interest coverage ratio: -806
COGS to revenue (%): 7.9857196542653135
R&D to revenue (%): 37.667543530001254
SG&A to revenue (%): 79.58787423274458
Free cash flow (dilution-adjusted): -6127000
Buyback yield (%): 0
Retained earnings: -131585000
Receivables turnover: 6.054607508532423
Capitalized R&D asset: 6014000
ROCI (R&D-adjusted, %): -0.0872674042169865
FCF margin (%): -38.3752975072028
Rule of 40 score: -38.3752975072028
Financial ratios for IDN — annual report dated 2023-12-31
Total revenue: 18906000
Gross profit: 17531000
Operating income: -2276000
Net income: -1980000
Capital expenditures: 93000
Operating cash flow: -647000
Depreciation & amortization: 282000
Net tangible assets: 8599000
Owner earnings: -1791000
Return on net tangible assets (%): -20.82800325619258
Buffett classification: The Gruesome
Stock price: 1.9
Shares outstanding: 20251221
Book value: 17276000
P/B ratio: 2.2272123118777496
Market cap (USD): 38477319.9
Debt to equity: 0
Current ratio: 2.2007042253521125
Quick ratio: 2.2007042253521125
COGS to revenue (%): 7.272823442293452
R&D to revenue (%): 24.754046334496984
SG&A to revenue (%): 80.01163651750767
Free cash flow (dilution-adjusted): -2743000
Buyback yield (%): 0
Retained earnings: -133565000
Receivables turnover: 4.019987242185839
Capitalized R&D asset: 8709380
ROCI (R&D-adjusted, %): -4.46661417561208
Rosenberg metric: 0.4722314599268374
FCF margin (%): -14.508621601607954
Revenue growth (%): 18.4141300263059
Rule of 40 score: 3.9055084246979472
Financial ratios for IDN — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 47000
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 20251221
Market cap (USD): 43945149.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDN — annual report dated 2024-12-31
Total revenue: 19997000
Gross profit: 18166000
Operating income: -1168000
Net income: -918000
Capital expenditures: 57000
Operating cash flow: -2694000
Depreciation & amortization: 436000
Net tangible assets: 7271000
Owner earnings: -539000
Return on net tangible assets (%): -7.413010590015129
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 20251221
Book value: 17747000
P/B ratio: 3.195098822336169
Market cap (USD): 56703418.8
Debt to equity: 0
Current ratio: 3.111111111111111
Quick ratio: 3.111111111111111
COGS to revenue (%): 9.156373456018404
R&D to revenue (%): 19.287893183977598
SG&A to revenue (%): 77.39660949142372
Free cash flow (dilution-adjusted): -5675000
Buyback yield (%): 0
Retained earnings: -134483000
Receivables turnover: 4.277433155080214
Capitalized R&D asset: 8977220
ROCI (R&D-adjusted, %): -8.087545055883139
Rosenberg metric: 0.13568376068376067
FCF margin (%): -28.379256888533277
Revenue growth (%): 5.770654818576113
Rule of 40 score: -22.608602069957165
Financial ratios for IDN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 20251221
Market cap (USD): 56703418.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IDN — quarterly report dated 2025-03-31
Total revenue: 4894000
Gross profit: 4392000
Operating income: -348000
Net income: -318000
Capital expenditures: 9000
Operating cash flow: 750000
Depreciation & amortization: 154000
Net tangible assets: 7072000
Owner earnings: -173000
Return on net tangible assets (%): -2.446266968325792
Buffett classification: The Gruesome
Stock price: 3.03
Shares outstanding: 20251221
Book value: 17608000
P/B ratio: 3.4848477754429803
Market cap (USD): 61361199.629999995
Debt to equity: 0
Current ratio: 1.9454911548971667
Quick ratio: 1.9454911548971667
COGS to revenue (%): 10.257458111973845
R&D to revenue (%): 26.29750715161422
SG&A to revenue (%): 70.55578259092766
Free cash flow (dilution-adjusted): 400000
Buyback yield (%): 0
Retained earnings: -134801000
Receivables turnover: 0.65201172395417
Capitalized R&D asset: 1287000
ROCI (R&D-adjusted, %): 2.699126753109288
FCF margin (%): 8.173273395995096
Rule of 40 score: 8.173273395995096
Financial ratios for IDN — quarterly report dated 2025-06-30
Total revenue: 5123000
Gross profit: 4600000
Operating income: -298000
Net income: -251000
Capital expenditures: 13000
Operating cash flow: 3134000
Depreciation & amortization: 171000
Net tangible assets: 7546000
Owner earnings: -93000
Return on net tangible assets (%): -1.2324410283593956
Buffett classification: The Gruesome
Stock price: 5.39
Shares outstanding: 20251221
Book value: 18005000
P/B ratio: 6.06243161288531
Market cap (USD): 109154081.19
Debt to equity: 0
Current ratio: 2.399328196008694
Quick ratio: 2.399328196008694
COGS to revenue (%): 10.208861994924849
R&D to revenue (%): 26.605504587155966
SG&A to revenue (%): 69.00253757563928
Free cash flow (dilution-adjusted): 2873000
Buyback yield (%): 0
Retained earnings: -135052000
Receivables turnover: 1.914424514200299
Capitalized R&D asset: 2225290
ROCI (R&D-adjusted, %): 0.8979933884618887
Rosenberg metric: 0.16161616161616163
FCF margin (%): 56.08042162795237
Revenue growth (%): 4.679199019207193
Rule of 40 score: 60.759620647159565
Financial ratios for IDN — quarterly report dated 2025-09-30
Total revenue: 6014000
Gross profit: 5443000
Operating income: 238000
Net income: 290000
Capital expenditures: 22000
Operating cash flow: -1737000
Depreciation & amortization: 188000
Net tangible assets: 8587000
Owner earnings: 456000
Return on net tangible assets (%): 5.310352858972866
Capex to operating income (%): 9.243697478991598
Buffett classification: The Great
Stock price: 5.2
P/E ratio: 90.78133551724139
Shares outstanding: 20251221
Book value: 18907000
P/B ratio: 5.569701655471519
Market cap (USD): 105306349.2
Debt to equity: 0
Current ratio: 2.283464566929134
Quick ratio: 2.283464566929134
Effective tax rate (%): 0
COGS to revenue (%): 9.494512803458596
R&D to revenue (%): 23.129364815430662
SG&A to revenue (%): 63.41868972397739
Free cash flow (dilution-adjusted): -1963000
Buyback yield (%): 0
Retained earnings: -134762000
Receivables turnover: 0.9573384272524673
Capitalized R&D asset: 2728920
ROCI (R&D-adjusted, %): 1.3033880694696596
Rosenberg metric: 0.6184886280264124
FCF margin (%): -32.64050548719654
Revenue growth (%): 17.39215303533086
Rule of 40 score: -15.248352451865681
Financial ratios for IDN — annual report dated 2025-12-31
Total revenue: 22666000
Gross profit: 20500000
Operating income: 1086000
Net income: 1273000
Capital expenditures: 52000
Operating cash flow: 4541000
Depreciation & amortization: 703000
Net tangible assets: 10518000
Owner earnings: 1924000
Return on net tangible assets (%): 18.292451036318692
Capex to operating income (%): 4.788213627992634
Buffett classification: The Great
Stock price: 6.68
P/E ratio: 106.2672083896308
Shares outstanding: 20251221
Book value: 20697000
P/B ratio: 6.536123896216843
Market cap (USD): 135278156.28
Debt to equity: 0
Current ratio: 3.675211416490486
Quick ratio: 3.675211416490486
Effective tax rate (%): 4.357625845229151
COGS to revenue (%): 9.556163416571076
R&D to revenue (%): 23.44480720021177
SG&A to revenue (%): 62.20771199152916
Free cash flow (dilution-adjusted): 3499000
Buyback yield (%): 0
Retained earnings: -133210000
Receivables turnover: 6.735809806835067
Capitalized R&D asset: 9442590
ROCI (R&D-adjusted, %): 5.915807082976245
Rosenberg metric: 0.605133523463832
FCF margin (%): 15.437218741727698
Revenue growth (%): 13.347002050307546
Rule of 40 score: 28.784220792035242